In addition, we also explored transcriptomic analyses using patient-derived AML samples in TCGA public datasets and discovered the mRNA level of CD80 was significantly higher in these FLT3-ITD AML patients compared with the FLT3-WT AML patients (Figure 1C). Here, FLT3 is linked to acute myeloid leukemia.